Suganthi Balasubramanian

机构：Regeneron (United States) · ORCID：0000-0003-2243-5948

发表论文 119 篇 · 总被引 76684 次 · h-index 51

代表论文

• Exome sequencing and analysis of 454,787 UK Biobank participants (2021 · Nature · 被引 1094)
• Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease (2022 · Nature Genetics · 被引 185)
• Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes (2021 · Nature Genetics · 被引 184)
• Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank (2022 · Nature Genetics · 被引 176)
• Germline Mutations in CIDEB and Protection against Liver Disease (2022 · New England Journal of Medicine · 被引 129)
• A deep catalogue of protein-coding variation in 983,578 individuals (2024 · Nature · 被引 119)